Welcome to our dedicated page for Amcor SEC filings (Ticker: AMCCF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amcor plc CDI (AMCCF) SEC filings page provides access to regulatory documents for Amcor plc, whose ordinary shares trade on the New York Stock Exchange under the symbol AMCR. These filings describe Amcor as a global producer of responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products, and they document key corporate, financial and governance events.
Annual and quarterly reports such as Form 10-K and Form 10-Q (when available) contain management’s discussion of Amcor’s packaging operations, its focus on light-weighted, recyclable and reusable packaging, and the use of recycled content. They also incorporate financial statements that reflect the impact of transactions such as the merger in which Berry Global Group, Inc. became a wholly owned subsidiary of Amcor.
Current reports on Form 8-K are particularly relevant for tracking significant events. Recent 8-K filings describe the completion of euro-denominated guaranteed senior notes due 2029 and 2033 issued by Amcor UK Finance plc and guaranteed on a senior unsecured basis by Amcor plc and certain affiliates. Other 8-Ks outline shareholder voting results at the annual general meeting, including approval of an amendment to Amcor’s memorandum of association to effect a 1-for-5 reverse stock split, and provide details on the planned implementation of that reverse split and its effect on ordinary shares and CHESS Depositary Interests.
Additional 8-K disclosures cover topics such as quarterly earnings press releases, pro forma financial information related to the Berry merger, and changes in senior management, including the transition of the chief financial officer role and associated employment and settlement agreements. Together, these documents help investors understand Amcor’s capital structure, governance decisions, and major corporate actions.
On this page, filings are updated as they are released through EDGAR. AI-powered tools can help summarize lengthy documents, highlight items such as reverse stock split mechanics, senior note terms, merger-related information, and executive transitions, and make it easier to locate specific details within Amcor’s SEC reporting history.
Amcor plc is implementing a 1-for-5 reverse stock split of its ordinary shares previously approved by shareholders. Amcor plans to file an amendment to its memorandum of association on January 14, 2026, with shares expected to begin trading on a split-adjusted basis on January 15, 2026. Every five ordinary shares issued, outstanding or held in treasury will be combined into one share, reducing outstanding ordinary shares from approximately 2.3 billion to approximately 461 million.
The amendment will also proportionately reduce authorized ordinary and preferred shares and increase their par value to $0.05 per share; no preferred shares are currently outstanding. No fractional shares will be issued, and shareholders entitled to fractions will receive cash instead. Equity-based awards under Amcor incentive plans will be adjusted proportionately. Amcor shares will continue to trade on the NYSE under “AMCR,” and its CHESS Depositary Interests will remain listed on the ASX under “AMC.”
Amcor plc director reports small share sale to cover taxes. A director of Amcor plc filed a Form 4 disclosing the sale of 4,148 ordinary shares on 12/03/2025 at a price of $8.439 per share. The explanation states that the sale was used to cover the reporting person’s corresponding tax liability. Following this transaction, the reporting person beneficially owned 82,535 ordinary shares, held directly.
Amcor plc director reported a sale of ordinary shares in a Form 4 filing. On 12/03/2025, the reporting person sold 6,058 ordinary shares of Amcor at a price of $8.439 per share. After this transaction, the director beneficially owned 71,302 shares, held directly.
According to the explanation provided, the 6,058-share sale was used to cover the reporting person’s corresponding tax liability, resulting in 8,221 shares. No derivative securities transactions were reported in this filing.
Amcor plc reported insider equity activity by one of its directors. On December 2, 2025, the director acquired 9,317 ordinary shares through the vesting and settlement of restricted stock units, reported with transaction code "M." After this transaction, the director directly held 305,649 ordinary shares.
The filing also shows changes in derivative holdings. A block of 9,317 restricted stock units previously outstanding was settled for ordinary shares at an exercise price of $0, reducing those derivative holdings to zero. In a separate transaction on December 1, 2025, the director received a new grant of 19,907 restricted stock units, which carry no exercise price and are scheduled to vest on December 1, 2026. Each restricted stock unit represents a contingent right to receive one Amcor ordinary share upon vesting.
Amcor plc director reports equity award activity. A director of Amcor plc (AMCR) acquired 15,159 ordinary shares on 12/02/2025 through the vesting and settlement of previously granted restricted stock units, reported as a transaction code "M". Following this transaction, the director directly held 15,159 ordinary shares.
In addition, the director received a new grant of 19,907 restricted stock units on 12/01/2025. Each restricted stock unit represents a contingent right to receive one ordinary share of Amcor upon vesting, and this new award is scheduled to vest in full on 12/01/2026.
Amcor plc reported an insider equity transaction by a director. On 12/02/2025, the director exercised 14,279 restricted stock units (RSUs) into the same number of ordinary shares in a transaction coded "M". After this, the director beneficially owned 43,802 ordinary shares directly. The filing also shows a new award of 19,907 RSUs on 12/01/2025, scheduled to vest on 12/01/2026. Each RSU represents a contingent right to receive one Amcor ordinary share upon vesting.
Amcor plc reported an insider equity transaction by a director. On December 2, 2025, the director exercised previously granted restricted stock units, acquiring 14,279 ordinary shares, bringing their directly held stake to 77,360 ordinary shares. These units were part of an award granted on December 2, 2024 that vested in full on December 2, 2025.
On December 1, 2025, the director also received a new grant of 19,907 restricted stock units, each representing a right to one ordinary share that is scheduled to vest on December 1, 2026. The Form 4 notes that these derivative securities are held directly by the reporting person.
Amcor plc director reports equity award activity and share acquisition. On December 2, 2025, the director acquired 14,279 ordinary shares through the vesting and settlement of restricted stock units, increasing direct beneficial ownership to 77,190 ordinary shares, plus 240 shares held indirectly by a trust. The filing also shows an award of 19,907 restricted stock units on December 1, 2025, which are scheduled to vest in full on December 1, 2026, each unit representing a right to receive one Amcor ordinary share upon vesting.
Amcor plc director reported routine equity activity involving restricted stock units. On December 2, 2025, 9,317 restricted stock units vested and were settled into the same number of ordinary shares at an exercise price of $0, increasing direct ownership to 24,484 ordinary shares. The filing also shows indirect holdings of 1,297.75 ordinary shares through a spouse trust, which includes an additional 0.75 share acquired via a dividend reinvestment program, and 60,902 ordinary shares through the JTG Trust.
Separately, on December 1, 2025, the director received a new award of 19,907 restricted stock units, each representing a right to receive one ordinary share. These units are scheduled to vest on December 1, 2026, and are held directly. After these transactions, the director continues to hold a mix of vested ordinary shares and unvested restricted stock units tied to Amcor’s share performance.
Amcor plc reported an insider equity transaction by a director. On December 2, 2025, the director exercised 14,279 restricted stock units (RSUs), receiving the same number of ordinary shares. Each RSU represents a right to one ordinary share upon vesting. After this transaction, the director beneficially owned 103,246 ordinary shares directly.
On December 1, 2025, the director was also awarded a new grant of 19,907 RSUs, which are scheduled to vest in full on December 1, 2026. Following these transactions, the director held 19,907 RSUs in addition to the ordinary shares, all reported as directly owned. The transactions were reported on a Form 4 and reflect routine equity compensation activity rather than a change in control.